Mumbai, June 5 -- The Reserve Bank of India's (RBI) monetary policy committee (MPC) has decided to keep the repo rate unchanged at 5.25% in its June 2026 bi-monthly monetary policy, Governor Sanjay Ma... Read More
Mumbai, June 5 -- The product is bioequivalent and therapeutically equivalent to the reference listed drug, Vimpat Injection, 200 mg/20 mL (10 mg/mL), of UCB Inc. According to IQVIA sales data for the... Read More
Mumbai, June 5 -- The said injection has been approved as an interchangeable biosimilar referencing to Lucentis, developed by Genentech. Ranluspec is the only interchangeable biosimilar ranibizumab a... Read More
Mumbai, June 5 -- The Indian rupee is regaining some momentum in opening trades on Friday as the global crude oil prices eased and market participants keenly awaited the RBI's MPC decision today. Heig... Read More
Mumbai, June 5 -- The product is bioequivalent and therapeutically equivalent to the reference listed drug, Xeljanz Tablets, of PF Prism C.V. It will be manufactured at APL Healthcare Unit IV, a wholl... Read More
Mumbai, June 5 -- This marked its first equity fund raise since its stock market debut in 2024. The renewable energy company said the issue attracted strong participation from a diversified group of ... Read More
Mumbai, June 5 -- NFP Sampoorna Foods will hold a meeting of the Board of Directors of the Company on 10 June 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More
Mumbai, June 5 -- Cipla has allotted 44,770 equity shares under ESOS on 04 June 2026. Consequently, the paid up equity share capital has increased to Rs 1,61,56,90,632 comprising of 80,78,45,316 equit... Read More
Mumbai, June 5 -- The equity shares of Aureate Tradde (Scrip Code: 544772) are listed effective 05 June 2026 and admitted to dealings on the exchange in the list of ''MT'' group securities. Published... Read More
Mumbai, June 5 -- A qualified Chartered Accountant, Sudhir brings over two decades of experience across finance, treasury, business transformation, mergers and acquisitions, IPOs, and operational lead... Read More